Following is a summary of current health news briefs.
Allergies, extra weight tied to bullying
NEW YORK (Reuters Health) - Kids who have food allergies or
are overweight may be especially likely to get bullied by their
peers, two new studies suggest. Not surprisingly, researchers
also found targets of bullying were more distressed and anxious
and had a worse quality of life, in general, than those who
weren't picked on.
Link between pot, psychosis goes both ways in kids
NEW YORK (Reuters Health) - Marijuana (cannabis) use may be
linked to the development of psychotic symptoms in teens - but
the reverse could also be true: psychosis in adolescents may be
linked to later pot use, according to a new Dutch study. "We
have focused mainly on temporal order; is it the chicken or the
egg? As the study shows, it is a bidirectional relationship,"
wrote the study's lead author Merel Griffith-Lendering, a
doctoral candidate at Leiden University in The Netherlands, in
an email to Reuters Health.
One in 12 in military has clogged heart arteries
NEW YORK (Reuters Health) - Just over one in 12 U.S.
service members who died in the Iraq and Afghanistan wars had
plaque buildup in the arteries around their hearts - an early
sign of heart disease, according to a new study. None of them
had been diagnosed with heart disease before deployment,
Obesity declining in young, poorer kids: study
NEW YORK (Reuters Health) - The number of low-income
preschoolers who qualify as obese or "extremely obese" has
dropped over the last decade, new data from the Centers for
Disease Control and Prevention show. Although the decline was
only "modest" and may not apply to all children, researchers
said it was still encouraging.
Japan approves Novo's new combination insulin Ryzodeg
COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk
approved its new combination insulin, that it plans to market
as Ryzodeg, for the treatment of diabetes. Ryzodeg is a
combination of Novo's new ultra long-acting insulin degludec,
or Tresiba, which Japan became the first country to approve in
September, and its rapid-acting insulin Novorapid.
UCB gets Japan clearance for two new drugs
BRUSSELS (Reuters) - Belgian pharmaceutical company UCB
further cementing its worldwide shift to a new generation of
drugs. The company said in a statement on Tuesday that the
Japanese Ministry of Health, Labour and Welfare had approved
UCB's Neupro patch to treat Parkinson's disease and
moderate-to-severe Restleg Legs Syndrome in adults.
U.S. reprimands some eye centers on LASIK surgery
ML () -
FDA approves Aegerion's cholesterol drug with strongest
RUG.XML () -
'Dystextia': Gibberish texts sound stroke alarm
NEW YORK (Reuters Health) - Imagine you were a devoted
husband, waiting to hear from your wife about her due date
after a visit to the obstetrician, and you saw these on your
phone: "every where thinging days nighing"
Little change in overtreatment at doctors' offices
NEW YORK (Reuters Health) - Although some Americans are
getting more of beneficial treatments that were underused in
the past, including drugs for heart disease, others are still
being overtested or overtreated for a range of conditions,
according to a new study. Researchers found U.S. doctors'
offices made progress on six of nine "quality indicators" for
recommended and underused therapies but only scaled back on two
of 11 unnecessary and potentially harmful health services.